陽光城(000671.SZ):陽光智博已向香港聯交所遞交H股首發並上市申請
格隆匯6月14日丨陽光城(000671.SZ)公佈,公司收到公司控股子公司上海陽光智博生活服務集團股份有限公司(“陽光智博”)通知,陽光智博已於2021年6月11日向香港聯交所遞交了首次公開發行境外上市外資股(H股)並在香港聯交所主板上市的申請資料。
陽光智博發行H股事項的相關資料於2021年6月11日刊登於香港聯交所網站,是陽光智博按照香港證監會及香港聯交所要求編制及刊發,為草擬版本且所載資料可能會適時作出更新及變動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.